Amkor Technology (AMKR) director exercises options, sells 5,000 shares under 10b5-1 plan
Rhea-AI Filing Summary
Amkor Technology, Inc. director Douglas A. Alexander exercised stock options and sold shares on August 7, 2026. He exercised a Director Stock Option to acquire 5,000 shares of common stock at an exercise price of $8.51 per share, then sold 5,000 shares of common stock at $55.81 per share in a sale described as an open market or private transaction. The option exercised was part of a grant covering 20,000 shares that vested in full on May 1, 2019. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 5,000 shares ($237K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
ALEXANDER DOUGLAS A
Role
Director
Sold
5,000 shs ($279K)
Approx. gross sale proceeds
$279K
Approx. exercise cost
$43K
Approx. pre-tax spread
$237K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Director Stock Option (Right-to-Buy) F2 | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,000 | $8.51 | $43K |
| Sale | Common Stock F1 | 5,000 | $55.81 | $279K |
Holdings After Transaction:
Director Stock Option (Right-to-Buy) — 14,657 shares (Direct);
Common Stock — 29,109 shares (Direct)
Footnotes (2)
- F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.
- F2. This stock option to acquire 20,000 shares of the Issuer's Common Stock was granted on May 1, 2018, vested in full on May 1, 2019.
Key Figures
Options exercised: 5,000 shares
Option exercise price: $8.51 per share
Shares sold: 5,000 shares
+2 more
5 metrics
Options exercised
5,000 shares
Director Stock Option converted into common stock on August 7, 2026
Option exercise price
$8.51 per share
Exercise price of Director Stock Option granted May 1, 2018
Shares sold
5,000 shares
Common stock sale on August 7, 2026 in open market or private transaction
Sale price
$55.81 per share
Per-share price for 5,000 common shares sold on August 7, 2026
Original option grant size
20,000 shares
Stock option grant to acquire 20,000 shares, fully vested May 1, 2019
Key Terms
Rule 10b5-1 trading plan, Director Stock Option (Right-to-Buy), Exercise or conversion of derivative security, open market or private transaction
4 terms
Rule 10b5-1 trading plan regulatory
"The sale reported ... was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Director Stock Option (Right-to-Buy) financial
"security_title: Director Stock Option (Right-to-Buy)"
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
open market or private transaction financial
"transaction_code_description: Sale in open market or private transaction"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What transactions did AMKR director Douglas A. Alexander report in this Form 4?
Douglas A. Alexander reported exercising options for 5,000 shares of Amkor Technology common stock at $8.51 per share and selling 5,000 shares at $55.81 per share in an open market or private transaction on August 7, 2026.
Was the August 7, 2026 AMKR stock sale under a Rule 10b5-1 plan?
Yes, the reported sale of 5,000 shares of Amkor Technology common stock at $55.81 per share was effected pursuant to a Rule 10b5-1 trading plan adopted by Douglas A. Alexander on May 8, 2026, indicating a pre-arranged trading framework.
What was the exercise price of the options Douglas A. Alexander exercised at AMKR?
The Director Stock Option exercised by Douglas A. Alexander had an exercise price of $8.51 per share for 5,000 underlying shares of Amkor Technology common stock, originating from a grant that covered 20,000 shares and fully vested on May 1, 2019.